Test Directory
| Test Code | ||||
| A1AN | ||||
| Test Name | ||||
| Alpha-1 Antitrypsin, Quant | ||||
| CPT Codes | ||||
| 82103 | ||||
| Expected Turnaround Time | ||||
| 3 - 5 days | ||||
| Clinical Utility | ||||
|
Useful in the detection of hereditary diseases in the production of alpha-1-antitrypsin (AAT). Decreased or nearly absent levels of AAT can be a factor in chronic obstructive lung disease and liver disease. An increased prevalence of non-MM phenotypes is found with cryptogenic cirrhosis and with chronic active hepatitis (CAH). Cirrhosis in a child should raise consideration of AAT deficiency or Wilson’s disease. Diagnosis of inflammatory states, if elevated, e.g., rheumatoid arthritis, bacterial infection, vasculitis, and neoplasia. |
||||
| Specimen and Container Info | ||||
|
Preferred Specimen Type: Serum Desired Specimen Volume: 2 mL Preferred Collection Container: Gold Top, Serum Separator |
||||
| Processing and Submission Instructions | ||||
|
Separator tubes: Contains clot activator and gel for separating serum from cells, but not anticoagulant. Separate serum from cells as soon as the clot has formed (30 minutes). If specimen is centrifuged before clotting is complete, a fibrin clot will form on top of the cell. This may cause the gel barrier to not be intact and could cause improper separation of serum and cells, possibly affecting test results. |
||||
| Transport Instructions | ||||
| Specimen must remain refrigerated until testing can be performed. | ||||
| Stability Requirements | ||||
|
||||
| Methodology | ||||
| Turbidimetric | ||||
| Reference Intervals | ||||
|
92-200 mg/dL |
||||
| Performing Location | ||||
| Roble Road Core Laboratory | ||||
| Testing Schedule | ||||
| Routine, 2 times per week | ||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.